1. Home
  2. MEHA vs MBIO Comparison

MEHA vs MBIO Comparison

Compare MEHA & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MEHA

Functional Brands Inc.

N/A

Current Price

$0.17

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.89

Market Cap

7.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MEHA
MBIO
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
7.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MEHA
MBIO
Price
$0.17
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.2M
32.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.53
52 Week High
$0.74
$7.00

Technical Indicators

Market Signals
Indicator
MEHA
MBIO
Relative Strength Index (RSI) 35.31 42.61
Support Level N/A $0.53
Resistance Level $0.29 $1.10
Average True Range (ATR) 0.03 0.06
MACD -0.00 -0.00
Stochastic Oscillator 5.71 19.03

Price Performance

Historical Comparison
MEHA
MBIO

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products; and 3) Corporate, which generates no revenue. Key revenue is generated from Kirkman.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: